EGYPT – Swiss multinational biotech giant Roche Pharma has signed a three-year strategic partnership agreement with the American University in Cairo (AUC) to empower patient organizations in Egypt. The agreement…
Read MoreTag: Roche
CAPED, Roche partner to deliver cervical cancer screening across India
INDIA – Roche Diagnostics India and the Cancer Awareness Prevention and Early Detection Trust (CAPED), a community outreach organisation, have partnered to launch a new HPV-based cervical cancer screening programme…
Read MoreRoche expands its collaboration with CDC to strengthen HIV & TB laboratory systems
SWITZERLAND – Roche has announced that it is expanding its collaboration with the U.S. Centers for Disease Control and Prevention (CDC) to strengthen laboratory systems in countries that have been…
Read MoreRoche expands collaboration with Janssen to develop companion diagnostics
SWITZERLAND — Roche has expanded its collaboration with Janssen Biotech to develop companion diagnostics for targeted therapies for an undisclosed amount. New agreement expands activities to include a wide range…
Read MoreRoche announces key appointments to its Corporate Executive Committee
SWITZERLAND – Roche has elected Teresa Graham as its new Chief Executive Officer (CEO) of Roche Pharmaceuticals and a member of the Corporate Executive Committee, effective March 2023. Teresa Graham…
Read MorePathkind Labs, Roche link up for diabetes management
INDIA – Gurugram-based Pathkind Labs has joined forces with Roche Diagnostics to release cardiac biomarker dubbed NTProBNP that will be used in the management of Type 2 Diabetes (T2DM). NTProBNP…
Read MoreRoche scores world’s first companion diagnostic certificate under new EU regulation
SWITZERLAND — Roche has received the first In Vitro Diagnostic Regulation (IVDR) certificate for a companion diagnostic (CDx), according to TÜV SÜD Product Service, the notified body that assessed the…
Read MoreRoche’s bispecific antibody for lymphoma gets priority review from FDA
USA – The US Food and Drug Administration (FDA) has accepted Swiss drugmaker Roche’s bispecific antibody glofitamab for people with relapsed or refractory large B-cell lymphoma (LBCL). Glofitamab is an…
Read MoreAfrica secures partnerships for sustainable cervical and breast cancer programs
AFRICA – Roche and Jhpiego team up to help prevent or reduce the morbidity and mortality of women facing breast or cervical cancer in countries in Africa, taking a woman-centred…
Read MoreRoche Diagnostics Egypt introduces new initiative to advance lab diagnosis of heart failure
EGYPT – Roche Diagnostics Egypt has unveiled a new initiative dubbed ‘Peptide for Life’ in partnership with the Egyptian Society of Cardiology aimed at availing better health care for patients…
Read More